KAMADA

Israel · 290 Employees
Kamada is focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins. AAT is a protein derived from human plasma with known and newly-discovered therapeutic roles given its immunomodulatory, anti-inflammatory, tissue-protective and antimicrobial properties. The Company's flagship product is GLASSIA®, the first liquid, ready-to-use, intravenous plasma-derived AAT product approved by the U.S. Food and Drug Administration. Kamada markets GLASSIA® in the U.S. through a strategic partnership with Baxalta (now part of Shire plc) and in other counties through local distributors. In addition to GLASSIA®, Kamada has a product line of six other pharmaceutical products administered by injection or infusion, that are marketed through distributors in more than 15 countries, including Israel, Russia, Brazil, India and other countries in Latin America and Asia. Kamada's rabies immune globulin (Human) product received FDA approval for Post-Exposure Prophylaxis against rabies infection and is marketed in the U.S. through a partnership with Kedrion Biopharma. Kamada has late-stage products in development, including an inhaled formulation of AAT for the treatment of AAT deficiency and, in addition, its intravenous AAT is in development for other indications, such as type-1 diabetes, GvHD and prevention of lung transplant rejection. Kamada also leverages its expertise and presence in the plasma-derived protein therapeutics market by distributing more than 10 complementary products in Israel that are manufactured by third parties.

概述

国家 Israel
成立时间 1990
总部 2 Holzman Street, Rehovot, Tel Aviv District, IL, 7670402
电话号码 +972 8-940-6472
网站 http://www.kamada.com
LinkedIn http://www.linkedin.com/company/kamada
Twitter https://twitter.com/kamada_pharma
Facebook
员工数 290
行业 pharmaceuticals,
简介 Kamada is focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins. AAT is a protein derived from human plasma with known and newly-discovered therapeutic roles given its immunomodulatory, anti-inflammatory, tissue-protective and antimicrobial properties. The Company's flagship product is GLASSIA®, the first liquid, ready-to-use, intravenous plasma-derived AAT product approved by the U.S. Food and Drug Administration. Kamada markets GLASSIA® in the U.S. through a strategic partnership with Baxalta (now part of Shire plc) and in other counties through local distributors. In addition to GLASSIA®, Kamada has a product line of six other pharmaceutical products administered by injection or infusion, that are marketed through distributors in more than 15 countries, including Israel, Russia, Brazil, India and other countries in Latin America and Asia. Kamada's rabies immune globulin (Human) product received FDA approval for Post-Exposure Prophylaxis against rabies infection and is marketed in the U.S. through a partnership with Kedrion Biopharma. Kamada has late-stage products in development, including an inhaled formulation of AAT for the treatment of AAT deficiency and, in addition, its intravenous AAT is in development for other indications, such as type-1 diabetes, GvHD and prevention of lung transplant rejection. Kamada also leverages its expertise and presence in the plasma-derived protein therapeutics market by distributing more than 10 complementary products in Israel that are manufactured by third parties.

技术

Act-On

Marketing Automation

GoDaddy Hosting

Hosting

Microsoft Office 365

Other

Outlook

Email Providers

常见问题

KAMADA 在哪里?

KAMADA 的总部位于 2 Holzman Street, Rehovot, Tel Aviv District, IL, 7670402

KAMADA 的电话号码是多少?

KAMADA 的电话号码是 +972 8-940-6472

KAMADA 的官方网站是什么?

KAMADA 的公司官方网站是 http://www.kamada.com

KAMADA 是做什么的?

KAMADA 的业务有哪些?

biopharmaceuticals,alpha 1 antitrypsin,immunoglobulins,type 1 diabetes,copd,graft versus host disease,immune modulation,plasma therapies,alpha 1 deficiency,rabies,anti d,rho d,orphan diseases,rare diseases,orphan drugs,lung transplantation,human plasma

KAMADA 的年收入是多少?

KAMADA 的收入是 103710000美元

KAMADA 有多少员工?

KAMADA 有 290 名员工

KAMADA 属于哪个行业?

KAMADA 从事以下行业: pharmaceuticals

KAMADA 使用什么技术?

KAMADA 使用的一些流行技术包括: Act-On,GoDaddy Hosting,Microsoft Office 365,Outlook

如何联系 KAMADA?

KAMADA 联系信息: 电话号码:+972 8-940-6472, 网站:http://www.kamada.com, 邮箱:ema***@***.com

KAMADA 的社交媒体链接是什么?

KAMADA 领英:http://www.linkedin.com/company/kamada,fackbook:,twitte:https://twitter.com/kamada_pharma

KAMADA 是一家上市公司吗?

是的,KAMADA是一家上市公司,在nasdaq公开挂牌上市,上市交易代码:KMDA

KAMADA 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 KAMADA?

KAMADA 有 0 家投资者,包括 。

管理层

Winston Ally

Director US Medical Affairs

Ruth Wolfson

Sr. VP Scientific Affairs

Ron Menachemy

Head of IT infrastructure, support and information security

Noga Alagem

Clinical Scientist and Medical Manager

Shai Lavy

Global Marketing Manager

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google